| http://www.w3.org/ns/prov#value | - This difference in FDA rating may explain why LMWH was chosen in this study 3 to 4 times more often than UFH despite being equally recommended by the AHA. There are also other benefits of LMWH over UFH including better bioavailability, more predictable pharmacokinetics, and longer plasma half-life as well as less risk of severe side effects such as osteoporosis, and heparin-induced thrombocytopeni
|
